Cholinergic and dopaminergic mechanisms involved in the recovery of circadian anticipation by aniracetam in aged rats

Pharmacology Biochemistry and Behavior

Volumn 72, Issue 1-2, 2002, Pages 45-53

  Tanaka, Yushiro ^a   Kurasawa, Mitsue ^a   Nakamura, Kazuo ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

Aged rats; Aniracetam; Cholinergic and dopaminergic systems; Mealtime associated circadian anticipation; Mode of action; Temporal regulation of behavior

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACETYLCHOLINE; AMPA RECEPTOR ANTAGONIST; ANIRACETAM; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; KETANSERIN; MECAMYLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SEROTONIN 2A ANTAGONIST; 2 PYRROLIDONE DERIVATIVE; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR;

ACETYLCHOLINE RELEASE; AGED; ANIMAL EXPERIMENT; ANTICIPATION; APPETITE; ARTICLE; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; FEEDING; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM; AGING; ANIMAL; DARKNESS; ILLUMINATION; PHYSIOLOGY; WISTAR RAT;

AGING; ANIMALS; CIRCADIAN RHYTHM; DARKNESS; LIGHTING; MALE; MOTOR ACTIVITY; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE;

EID: 0036204712     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00734-1     Document Type: Article

References (56)

1. A chronometric approach of the study of feeding behavior
2. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment
3. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries
4. Antagonism by abecarnil of enhanced acetylcholine release in the rat brain during anticipation but not consumption of food
5. Oxracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo
6. The neurochemistry of vascular dementia
7. Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus
8. Feeding increases dopamine metabolism in the rat brain
9. Methamphetamine induced locomotor rhythm entrains to restricted daily feeding in SCN lesioned rats
10. Circadian system in rats: Oscillators within and outside the suprachiasmatic nucleus
11. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal
12. NMDA and kinate-evoked release of nitric oxide and classical transmitters in the rat striatum: In vivo evidence that nitric oxide may play a neuroprotective role
13. Effects of aniracetam on impaired sleep patterns in stroke-prone spontaneously hypertensive rats
14. Enhancement of contextual fear-conditioning by putative (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice
15. Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity
16. Chronotherapy for circadian rhythm disorders in elderly patients with dementia
17. The limbic system and food-anticipatory circadian rhythms in the rat: Ablation and dopamine blocking studies
18. Effects of aging on food-entrained circadian rhythms in the rat
19. Effect of aging on monoamines and their metabolites in the rat brain
20. The dopamine and serotonin systems during aging in human and rodent brain. A brief review
21. The circadian visual system
22. 2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats
23. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam
24. Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats
25. Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanisms
26. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam
27. Antidepressant-like effects of aniracetam in aged rats and its mode of action
28. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam
29. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam
30. Impulsivity and AMPA receptors: Aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats
31. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats
32. Attenuating effect of arecoline and physostigmine on an impairment of mealtime-associated activity rhythm in old rats
33. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Placebo controlled double-blind trial
34. Acetylcholine and hallucinations; disease-related compared to drug-induced alternations in human consciousness
35. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices
36. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
37. 1A agonists
38. Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats
39. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alteration performance in rats
40. Age-related impairment of food anticipatory locomotor activity in rats
41. Aging impairs methamphetamine-induced free-running and anticipatory locomotor activity rhythms in rats
42. Involvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats
43. Attenuating effect of serotonin receptor antagonists on impairment of mealtime-associated activity rhythm in old rats
44. Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP
45. Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP
46. The lateral hypothalamus: A primary site mediating excitatory amino acid-elicited eating
47. Glutamatergic regulation of basal and stimulation-activated dopamine release in the prefrontal cortex
48. 2 receptor-mediated head-twitch response in rodents as a hallucination model
49. Recovery of diminished mealtime-associated anticipatory behavior by aniracetam in aged rats
50. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia
51. Effect of stimulation of nicotinic cholinergic receptors on cortical cerebral blood flow and changes in the effect during aging in anesthetized rats
52. Restricted-feeding-induced anticipatory activity rhythm is associated with a phase-shift of the expression of mPer1 and mPer2 mRNA in the cerebral cortex and hippocampus but not in the suprachiasmatic nucleus of mice
53. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease
54. 2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphé nucleus and 5-HT release and metabolism in the frontal cortex
55. Decrease of brain acetylcholine release in aging freely-moving rats
56. 2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats